What is the difference between the Miami criteria and the modified Miami criteria for intraoperative parathyroid hormone (PTH) monitoring?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Miami vs. Modified Miami Criteria for Intraoperative PTH Monitoring

The modified Miami criteria should be used over the standard Miami criteria for intraoperative PTH monitoring during parathyroidectomy, as they demonstrate superior diagnostic accuracy with the highest diagnostic odds ratio (79.71) compared to conventional Miami criteria (60.00). 1

Key Differences Between the Criteria

Standard Miami Criteria 2

  • Timing: PTH samples taken at 5 and 10 minutes after removal of pathological gland
  • Definition of cure: ≥50% reduction in PTH concentration at 10 minutes compared to the highest baseline level (either pre-incision or pre-excision)
  • Baseline reference: Uses the higher of pre-incision or pre-excision PTH values
  • Success rate: Provides surgeon certainty of cure in 97% of cases

Modified Miami Criteria 1

  • Timing: PTH measurement at 15 minutes or more post-excision (extended from 10 minutes)
  • Definition of cure: ≥50% reduction from highest baseline level
  • Key advantage: The extended timing allows for more complete clearance of PTH, particularly important given PTH's half-life and the presence of C-terminal fragments that persist longer

Why Modified Miami Performs Better

The modified Miami criteria optimize diagnostic accuracy by:

  • Minimizing false positives: The longer 15-minute timepoint reduces the risk of declaring success when a second "switched-off" adenoma remains (a critical issue in the 15% of cases with multigland disease) 2
  • Reducing unnecessary exploration: Better specificity means fewer patients undergo extended bilateral neck exploration unnecessarily 1
  • Lowering revision surgery rates: Superior negative predictive value identifies persistent disease more reliably 1

Clinical Application Algorithm

When to use IOPTH monitoring:

  • All minimally invasive parathyroidectomies for primary hyperparathyroidism
  • Cases with concordant preoperative imaging showing single adenoma (though some debate exists about necessity in this scenario) 2
  • Essential for detecting multigland disease intraoperatively

How to apply modified Miami criteria:

  1. Obtain baseline PTH (both pre-incision and pre-excision; use the higher value)
  2. Remove suspected adenoma
  3. Wait 15 minutes (not 10 minutes as in standard Miami)
  4. Measure PTH
  5. Success = ≥50% drop from highest baseline

If criteria NOT met at 20 minutes:

  • Continue cervical exploration
  • Often requires conversion to full bilateral cervical exploration 2

Important Caveats and Pitfalls

The "Switched-Off" Adenoma Problem 2

In multigland disease (15% of primary hyperparathyroidism cases), up to two-thirds of patients may show adequate PTH drop after removing the first (dominant) adenoma, leaving a second temporarily suppressed adenoma undetected. This is the most problematic false-positive scenario and a key reason why the extended 15-minute timepoint of modified Miami criteria improves accuracy.

Assay Generation Matters 3

  • Second-generation assays measure C-terminal fragments with longer half-lives, causing slower PTH decline
  • Third-generation assays show more rapid PTH decrease (drop observable at 10 minutes vs. 20+ minutes with second-generation)
  • Critical point: Use the same assay consistently for all measurements in a given patient to accurately assess trends

When IOPTH May Not Be Necessary 2

Some evidence suggests IOPTH is not required when preoperative imaging is concordant on two distinct imaging modalities showing a single adenoma. However, this remains controversial, and IOPTH still improves cure rates in minimally invasive surgery.

Operative Failure Despite Meeting Criteria 4

Failures occur in approximately 1.8-4.1% of cases even when criteria are met, typically due to:

  • Parathyroid carcinoma with metastases
  • Non-localizing or ectopic adenomas
  • Severe vitamin D deficiency (should be corrected preoperatively)
  • Multigland disease with dominant adenoma removed first

The modified Miami criteria represent the current best practice for IOPTH-guided parathyroidectomy, balancing sensitivity and specificity to minimize both unnecessary exploration and revision surgery rates. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.